Comparative PK Assessment Study of Casdatifan in Moderate Hepatically Impaired Participants Versus Matched Participants With Normal Hepatic Function

Conditions

• Healthy Participants
• Hepatic Impairment

Interventions

• DRUG: Casdatifan

Sponsor

Arcus Biosciences, Inc.